Q1 sales miss; organic growth guidance unchanged
06/05/24 -"Demant’s Q1 sales missed the company-compiled consensus. The low-single-digit growth was led by positive contributions from Hearing Aids and Diagnostics, but Hearing Care came in flat (and also ..."
Pages
60
Language
English
Published on
06/05/24
You may also be interested by these reports :
24/05/24
Besides the improving end markets and the better/newer products being launched, the firm’s tangible progress on its strategic initiatives including: ...
22/05/24
We have obtained more details and feedback after attending Clariane’s Capital Market Day and discussing with several senior managers. The company’s ...
21/05/24
Following the release of reassuring-looking terms for the long-awaited recaps and steady progress on asset disposals, Clariane can now refocus on its ...
17/05/24
Clariane communicated more details regarding its projected capital increases and the entry of a new anchor shareholder in its capital. We take this ...